非复杂腹主动脉瘤的腔内与开放修复:系统评价与荟萃分析
该系统评价与荟萃分析比较了肾下型非复杂腹主动脉瘤行EVAR与OSR的短期和长期结局。EVAR显著降低围手术期死亡率,但长期全因死亡率无差异,且再干预和肢体移植物闭塞风险更高。
要点
- EVAR围手术期死亡率显著低于OSR。
- 长期全因死亡率两者无显著差异。
- EVAR再干预和肢体移植物闭塞风险更高。
核心结论
- EVAR较OSR降低围手术期死亡率,但不改善长期全因死亡率。
- EVAR术后晚期动脉瘤相关死亡、再干预和肢体移植物闭塞更常见。
研究设计与样本
- 系统评价与荟萃分析,遵循PRISMA指南。
- 纳入比较肾下型非复杂腹主动脉瘤EVAR与OSR的研究。
- 采用随机效应模型进行统计分析。
主要发现
- EVAR较OSR显著降低围手术期死亡率(OR=0.45;95%CI:0.27-0.75;P=0.002;I2=63%)。
- 最长随访(6-15年)全因死亡率无显著差异(OR=1.06;95%CI:0.97-1.17;P=0.22)。
- 动脉瘤相关死亡率EVAR有非显著升高趋势(OR=1.17;95%CI:0.88-1.56;P=0.29)。
- EVAR再干预显著更频繁(OR=2.27;95%CI:1.32-3.93;P=0.003)。
- EVAR肢体移植物闭塞风险较OSR增加4倍以上(OR=4.07;95%CI:2.15-7.71;P<0.0001)。
关键数值与推荐
- 内漏是EVAR最常见的相关并发症。
- Enzen试验中Zenith Flex较Endurant II的I型内漏和肢体移植物闭塞率更高。
临床怎么用
- EVAR可用于降低围手术期风险,但需终身监测。
- 患者选择应权衡EVAR再干预和肢体移植物闭塞风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk of rupture and mortality associated with abdominal aortic aneurysms (AAAs) necessitates timely surgical intervention. Open surgical repair (OSR) and endovascular aneurysm repair (EVAR) are the 2 primary surgical techniques, frequently compared for efficacy and safety. EVAR is less invasive and reduces perioperative mortality but carries a higher risk of long-term complications. This meta-analysis evaluates short- and long-term outcomes of EVAR and OSR in infrarenal noncomplex AAA. METHODS: A systematic review and meta-analysis was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Primary outcomes included perioperative mortality, long-term all-cause mortality, and aneurysm-related mortality. Secondary outcomes assessed reintervention, complication and limb graft occlusion (LGO) rates. Random-effects model were used for statistical analysis. RESULTS: Compared with OSR, EVAR significantly reduced perioperative mortality (odds ratio [OR] = 0.45; 95% confidence interval [CI]: 0.27-0.75; P = 0.002; I2 = 63%). At the longest follow-up (6-15 years), all-cause mortality did not differ significantly (OR = 1.06; 95% CI: 0.97-1.17; P = 0.22). Aneurysm-related mortality showed a nonsignificant trend toward higher rates after EVAR (OR = 1.17; 95% CI: 0.88-1.56; P = 0.29). Secondary interventions were significantly more frequent after EVAR (OR = 2.27; 95% CI: 1.32-3.93; P = 0.003). Pooled analysis demonstrated over 4-fold increased odds of LGO with EVAR compared to OSR (OR = 4.07; 95% CI: 2.15-7.71; P < 0.0001). Endoleaks were the most common EVAR-related complication, with higher rates of type I endoleak and LGO for Zenith Flex versus Endurant II in the Enzen Trial. CONCLUSION: EVAR confers a perioperative survival benefit over OSR but does not improve long-term all-cause mortality. Late aneurysm-related deaths, reinterventions, and LGO are more frequent after EVAR, emphasizing the need for lifelong surveillance and careful patient selection.
引用
- Lim EQ, O'Brien G. Endovascular versus Open Repair for Non-Complex Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis. Ann Vasc Surg. 2025. PMID: 41046100. doi:10.1016/j.avsg.2025.09.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。